Not recruitingISRCTN68736636

The European First Episode Schizophrenia Trial (EUFEST): Comparison of outcome in first episode schizophrenia with different low dose antipsychotic drug regimens

Research studyAges 18+Multiple countries

The study in practice

Understand this study

Listed age limits: from 18 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: European Group for Research in Schizophrenia (EGRIS) (Austria)
Sponsor type: Unknown or unclear
Study type: Other
Intervention type: Other / unclear
Study phase: Not clearly listed
Locations: France, Switzerland, Belgium, ...
Age range: Over 18 Years
Official registry ID: ISRCTN68736636
Official title: Show the full official title
The European First Episode Schizophrenia Trial (EUFEST): Comparison of outcome in first episode schizophrenia with different low dose antipsychotic drug regimens

Not recruiting

Austria · Belgium · Bulgaria

11 more locations

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is European Group for Research in Schizophrenia (EGRIS) (Austria).

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not recruiting.